Loading clinical trials...
Loading clinical trials...
A Phase 1b Study Evaluating Combinations With PSCA-Targeting Chimeric Antigen Receptor (CAR)-T Cells for Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
Conditions
Interventions
Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
Biopsy
+6 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
July 19, 2024
Primary Completion Date
November 11, 2028
Completion Date
November 11, 2028
Last Updated
November 19, 2025
NCT04693377
NCT06526299
NCT06705686
NCT04550494
NCT06305598
NCT04489719
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions